Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Gastroenterology ; 131(1): 108-16, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16831595

ABSTRACT

BACKGROUND & AIMS: An increase in Rho kinase (ROK) activity has been associated with agonist-induced sustained contraction of the smooth muscle, but its role in the pathophysiology of spontaneously tonic smooth muscle is not known. METHODS: Present studies examined the effects of ROK inhibitor Y-27632 in the tonic smooth muscle of the rat internal anal sphincter (IAS) versus in the flanking phasic smooth muscle of the rectum. In addition, studies were performed to determine the relationship between the decreases in the basal IAS tone and the ROK activity. Confocal microscopic studies determined the cellular distribution of the smooth muscle-predominant isoform of ROK (ROCK-II) in the smooth muscle cells (SMCs). RESULTS: In in vitro studies using neurohumoral inhibitors and tetrodotoxin and the use of SMCs demonstrate direct relaxation of the IAS SMCs by Y-27632. The ROK inhibitor was more potent in the IAS than in the rectal smooth muscle. The IAS relaxation by Y-27632 correlated specifically with the decrease in ROK activity. Confocal microscopy revealed high levels of ROCK-II toward the periphery of the IAS SMCs. In in vivo studies, the lower doses of Y-27632 caused a potent and selective decrease in the IAS pressures without any adverse cardiovascular systemic effects. The ROK inhibitor also caused potent relaxation of the hypertensive IAS. CONCLUSIONS: RhoA/ROK play a crucial role in the maintenance of the basal tone in the IAS, and ROK inhibitors have a therapeutic potential in the IAS dysfunction characterized by the hypertensive IAS.


Subject(s)
Amides/therapeutic use , Anal Canal/physiopathology , Enzyme Inhibitors/therapeutic use , Muscle Hypertonia/drug therapy , Muscle, Smooth/physiopathology , Protein Serine-Threonine Kinases/metabolism , Pyridines/therapeutic use , Anal Canal/drug effects , Anal Canal/enzymology , Animals , Disease Models, Animal , In Vitro Techniques , Intracellular Signaling Peptides and Proteins , Muscle Hypertonia/enzymology , Muscle Hypertonia/physiopathology , Muscle Relaxation/drug effects , Muscle, Smooth/drug effects , Muscle, Smooth/enzymology , Protein Serine-Threonine Kinases/antagonists & inhibitors , Rats , Rats, Sprague-Dawley , Tetrodotoxin/therapeutic use , Treatment Outcome , rho-Associated Kinases
2.
J Neurosurg ; 87(3): 431-5, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9285610

ABSTRACT

Induction of hypothermia is used routinely in neurosurgical and cardiovascular operations to protect the brain from ischemic insult. However, despite a plethora of experimental evidence supporting the use of hypothermia to protect the brain from ischemia, clinical experience using deliberate hypothermia in humans has not shown a convincing benefit. The authors tested the hypothesis that hypothermia and rewarming alter tone in human cerebral vessels and may interfere with cerebral perfusion in the setting of deliberate hypothermia. They examined human cerebral arteries during hypothermia (32 degrees C and 17 degrees C) and during rewarming to delineate the direct effects of cooling and rewarming on cerebrovascular tone. Artery segments obtained from autopsy material and from specimens excised at elective temporal lobectomies were tested in tissue baths using isometric tension measurements. Temperature-induced changes in vascular tone were measured and quantified with respect to contractile responses to serotonin (5-HT; 10(-6) M). Cooling induced mild relaxation in cerebral vessels (-38 +/- 12% 5-HT response in 50 vessels from autopsy specimens, -69 +/- 10% 5-HT response in 51 vessels from lobectomy specimens). On rewarming, vessels contracted significantly beyond their baseline tone (108 +/- 18% 5-HT response in 50 vessels from autopsy specimens, 42 +/- 12% 5-HT response in 51 vessels from lobectomy specimens). Rewarming-induced hypercontractility was inhibited by the tyrosine kinase inhibitor genistein (-5 +/- 7% vs. 70 +/- 23% 5-HT response, genistein vs. control, 14 segments, p < 0.05) and enhanced by the tyrosine phosphatase inhibitor sodium orthovanadate (339 +/- 54% vs. 104 +/- 20% 5-HT response, sodium orthovanadate vs. control, five segments, p < 0.05), indicating a possible role for tyrosine kinase activation in the rewarming-induced contraction.


Subject(s)
Cerebral Arteries/physiopathology , Hypothermia, Induced , Muscle Contraction , Muscle Hypertonia/enzymology , Muscle, Smooth, Vascular/physiopathology , Protein-Tyrosine Kinases/antagonists & inhibitors , Rewarming , Aged , Cerebral Arteries/enzymology , Enzyme Activation/drug effects , Genistein , Humans , Isoflavones/pharmacology , Middle Aged , Muscle Contraction/drug effects , Muscle, Smooth, Vascular/enzymology , Protein Tyrosine Phosphatases/antagonists & inhibitors , Temperature , Vanadates/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...